Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Retained Earnings (2016 - 2025)

Adma Biologics' Retained Earnings history spans 14 years, with the latest figure at -$161.7 million for Q4 2025.

  • For Q4 2025, Retained Earnings rose 47.61% year-over-year to -$161.7 million; the TTM value through Dec 2025 reached -$161.7 million, up 47.61%, while the annual FY2025 figure was -$161.7 million, 47.61% up from the prior year.
  • Retained Earnings reached -$161.7 million in Q4 2025 per ADMA's latest filing, up from -$211.0 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$161.7 million in Q4 2025 to a low of -$506.3 million in Q4 2023.
  • Average Retained Earnings over 5 years is -$396.1 million, with a median of -$428.8 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: decreased 26.37% in 2021, then skyrocketed 49.81% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$412.1 million in 2021, then fell by 15.99% to -$478.0 million in 2022, then fell by 5.91% to -$506.3 million in 2023, then soared by 39.05% to -$308.6 million in 2024, then surged by 47.61% to -$161.7 million in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Retained Earnings are -$161.7 million (Q4 2025), -$211.0 million (Q3 2025), and -$247.5 million (Q2 2025).